Kyverna Therapeutics, Inc.
KYTX
DELAYED 1 MONTH

10 insider filings · Latest: May 27, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 27, 2026May 29 8:30 PMIan T ClarkDirector
Grant/Award
20,582$8.5920,582(D)

View →

May 27, 2026May 29 8:30 PMFred E CohenDirector
Grant/Award
20,582$8.5920,582(D)

View →

May 27, 2026May 29 8:30 PMBeth C SeidenbergDirector
Grant/Award
20,582$8.5920,582(D)

View →

May 27, 2026May 29 8:30 PMMert AktarDirector
Grant/Award
20,582$8.5920,582(D)

View →

May 18, 2026May 20 8:30 PMGregory S. MartiniChief Financial Officer
Grant/Award
325,000$8.54325,000(D)

View →

May 4, 2026May 6 8:30 PMNadia DacChief Commercial Officer
Grant/Award
300,000$9.00300,000(D)

View →

Mar 13, 2026Mar 17 8:30 PMWarner Weston BiddleDirector, Chief Executive Officer
Grant/Award
350,000$8.95350,000(D)

View →

Mar 13, 2026Mar 17 8:30 PMNaji GehchanExhibit 24 - Power of Attorney Chief Medical & Development Officer
Grant/Award
105,000$8.95105,000(D)

View →

Feb 24, 2026Mar 4 9:30 PMAndrew Craig MillerDirector
Grant/Award
42,945$7.9542,945(D)

View →